Safi R. Bahcall

2012

In 2012, Safi R. Bahcall earned a total compensation of $2.1M as Former President and Chief Executive Officer at Synta Pharmaceuticals, a 28% increase compared to previous year.

Compensation breakdown

Bonus$250,000
Option Awards$1,269,450
Salary$459,167
Other$80,674
Total$2,059,291

Bahcall received $1.3M in option awards, accounting for 62% of the total pay in 2012.

Bahcall also received $250K in bonus, $459.2K in salary and $80.7K in other compensation.

Rankings

In 2012, Safi R. Bahcall's compensation ranked 3,473rd out of 11,487 executives tracked by ExecPay. In other words, Bahcall earned more than 69.8% of executives.

ClassificationRankingPercentile
All
3,473
out of 11,487
70th
Division
Manufacturing
1,194
out of 4,253
72nd
Major group
Chemicals And Allied Products
266
out of 1,198
78th
Industry group
Drugs
156
out of 920
83rd
Industry
Pharmaceutical Preparations
124
out of 700
82nd
Source: SEC filing on April 30, 2014.

Bahcall's colleagues

We found four more compensation records of executives who worked with Safi R. Bahcall at Synta Pharmaceuticals in 2012.

2012

Vojo Vukovic

Synta Pharmaceuticals

Chief Medical Officer

2012

Amar Singh

Synta Pharmaceuticals

Former Senior Vice President, Chief Business Officer

2012

Keith Ehrlich

Synta Pharmaceuticals

Chief Financial Officer

2012

Wendy Rieder

Synta Pharmaceuticals

General Counsel

In-depth

You may also like